FHND9041

· Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FHND9041, covering 2025-01-06 to 2025-01-06. Get the full timeline:

Most recent: Clinical Trial Update: FHND9041 Versus Afatinib for Non-small Cell Lung Cancer [Phase 3]